التفاصيل البيبلوغرافية
| العنوان: |
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care. |
| المؤلفون: |
Sidana, Surbhi, Allmer, Cristine, Larson, Melissa C., Dueck, Amylou, Yost, Kathleen, Warsame, Rahma, Thanarajasingam, Gita, Cerhan, James R., Paludo, Jonas, Rajkumar, S. Vincent, Habermann, Thomas M., Nowakowski, Grzegorz S., Yi Lin, Gertz, Morie A., Witzig, Thomas, Dispenzieri, Angela, Gonsalves, Wilson I., Ansell, Stephen M., Thompson, Carrie A., Kumar, Shaji K. |
| المصدر: |
JCO Oncology Practice; Aug2022, Vol. 18 Issue 8, pe1320-e1333, 15p |
| مصطلحات موضوعية: |
CANCER patient psychology, WELL-being, MEDICAL quality control, CLINICAL trials, HEALTH services accessibility, HEALTH outcome assessment, PATIENT satisfaction, PATIENTS' attitudes, INCOME, QUALITY of life, FINANCIAL stress, COMMUNICATION, QUESTIONNAIRES, DESCRIPTIVE statistics, RESEARCH funding, PATIENT care, MULTIPLE myeloma, LYMPHOMAS, LONGITUDINAL method |
| مصطلحات جغرافية: |
MINNESOTA |
| مستخلص: |
PURPOSE Patients' concerns regarding clinical trial (CT) participation include apprehension about side effects, quality of life (QoL), financial burden, and quality of care. METHODS We prospectively evaluated the experience of patients with multiple myeloma or lymphoma who were treated on CTs (CT group, n = 35) versus patients treated with standard approaches (non-CT group, n = 88) focusing on QoL, financial burden of care, and patients' perception of quality of care over a 1-year period. RESULTS There were no significant differences in any of the patient-reported outcomes in CT versus non-CT groups. We observed an initial decline in overall QoL in the first 3 months across both groups, driven primarily by physical and functional well-being. QoL gradually improved and was above baseline by month 12. Patients reported highest improvement in the functional well-being subdomain. Patients in both groups reported high satisfaction with the quality of care received, and there were no differences in overall satisfaction, communication with team, or access to care. At baseline, 16%-19% of patients reported financial burden, which increased to a peak of 33% in the CT group and to 49% in the non-CT group over the course of 1 year. There was no significant difference in financial burden in the two groups overall. Most of the patients reported getting all the care that was deemed medically necessary in both groups. However, a significant proportion of patients reported having to make other kinds of financial sacrifices because of their cancer (CT group: 33% of patients at baseline and 21%-40% over 1 year; non-CT group: 19% at baseline and 25%-36% over 1 year). CONCLUSION Patients treated on CTs reported comparable QoL and quality of care with the non-CT group. A high proportion of patients reported financial burden over time in both groups. Our findings can serve as a guide to educate patients regarding CT participation and highlight the need to address the significant financial burden experienced by patients with cancer. [ABSTRACT FROM AUTHOR] |
|
Copyright of JCO Oncology Practice is the property of American Society of Clinical Oncology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
